Zymeworks Inc. (NASDAQ:ZYME) Q4 2022 Earnings Conference Call March 7, 2023 4:30 PM ET

Company Participants

Jack Spinks - Head of Investor Relations

Chris Astle - Senior Vice President & Chief Financial Officer

Kenneth Galbraith - Chair & Chief Executive Officer

Conference Call Participants

Yigal Nochomovitz - Citi

James Shin - Wells Fargo

Stephen Willey - Stifel

Brian Cheng - JPMorgan

Charles Zhu - Guggenheim

Andrew Berens - SVB Leerink

David Martin - Bloom Burton

Operator

Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Zymeworks Fourth Quarter and Full Year 2022 Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions]

At this time, I would like to turn the conference over to Mr. Jack Spinks of Investor Relations for Zymeworks. Sir, you may begin

Jack Spinks

Good afternoon, and welcome, everyone. My name is Jack Spinks, Head of Investor Relations here at Zymeworks. Today, we will discuss our fourth quarter and full year 2022 financial results, as well as provide an update to our ongoing business.

Before we begin, I'd like to remind you that we will be making a number of forward-looking statements during this call, including, without limitation, those forward-looking statements identified in our presentation slides and the accompanying oral commentary. Forward-looking statements are based upon our current expectations and various assumptions and are subject to the usual risks and uncertainties associated with companies in our industry and at our stage of development. For a discussion of those risks and uncertainties, we refer you to our latest SEC filings is found on our website and as filed with the SEC.

Later in this call, Chris Astle, our Senior Vice President and Chief Financial Officer, will be discussing our financial results, including certain non-GAAP measures. A description of our GAAP measures and a reconciliation to the most directly comparable financial measures as determined in accordance with GAAP are described in detail in our press release, which is available on our website at www.zymeworks.com under the Investor Relations tab. As a reminder, the audio and slides from this call will also be available on the Zymeworks website later today.

Now I will turn the call over to Chris, our Senior Vice President and Chief Financial Officer. Chris?

Chris Astle

Thanks, Jack, and thank you, everyone, for joining us today for our fourth quarter and full year 2022 earnings call. As a reminder, I'd like to note that while I'll be presenting the prepared remarks today, Kenneth Galbraith, our Chair and CEO; and other members of our executive team will be available for Q&A following this portion of the call. With that, I'd like to begin today's call with an overview of our financial results followed by a few recent developments and noteworthy updates across our business before we open the lines for Q&A.